Background Respiratory syncytial virus (RSV) is a leading cause of pediatric death, with >99%
of mortality occurring in low- and lower middle-income countries. At least half of RSV-…

Background: According to the World Health Organization, the global burden of nosocomial
infections is poorly characterized as surveillance systems are lacking. Nosocomial infections …

Background Respiratory syncytial virus (RSV) infection is an important cause of hospitalization
and death in young children. The majority of deaths (99%) occur in low- and lower-middle…

The European Medicines Agency and the US Food and Drug Administration have recently
approved a maternal vaccine for respiratory syncytial virus. The US Food and Drug …

Background: To meet regulatory approval, interventions must demonstrate efficacy against
a primary outcome in randomized clinical trials. However, when there are multiple clinically …

Background Respiratory syncytial virus (RSV) is a leading cause of childhood mortality in
infants below 6 months of age. In low-income and middle-income countries (LMICs), the public …

1. Löwensteyn YN, Mazur NI, Nair H, Willemsen JE, van Thiel G, Bont L, on behalf of the RSV
GOLD III—ICU Network Study Group. Describing global pediatric RSV disease at intensive …

Bayesian statistics is an approach to data analysis based on Bayes’ theorem, where available
knowledge about parameters in a statistical model is updated with the information in …

Respiratory syncytial virus (RSV) is a major health problem. A better understanding of the
geographical and temporal dynamics of RSV circulation will assist in tracking resistance …

To help researchers conduct a systematic review or meta-analysis as efficiently and transparently
as possible, we designed a tool to accelerate the step of screening titles and abstracts. …